跳转至内容
Merck

PHR1423

Supelco

硝普钠

Pharmaceutical Secondary Standard; Certified Reference Material

别名:

硝普钠 二水合物, SNP, 五氰基亚硝酰基铁酸钠, 硝基铁酸氰化钠, 硝普盐 钠

登录查看公司和协议定价


About This Item

线性分子式:
Na2[Fe(CN)5NO] · 2H2O
CAS号:
分子量:
297.95
EC號碼:
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

certified reference material
pharmaceutical secondary standard

品質等級

agency

traceable to USP 1614501

API 家族

sodium nitroprusside

CofA

current certificate can be downloaded

技術

HPLC: suitable
gas chromatography (GC): suitable

應用

pharmaceutical (small molecule)

格式

neat

儲存溫度

2-8°C

SMILES 字串

[Na+].[Na+].[H]O[H].[H]O[H].O=N[Fe--](C#N)(C#N)(C#N)(C#N)C#N

InChI

1S/5CN.Fe.NO.2Na.2H2O/c5*1-2;;1-2;;;;/h;;;;;;;;;2*1H2/q;;;;;2*-1;2*+1;;

InChI 密鑰

OIRZWVYIQXBRFC-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般說明

用于质量控制的已认证的药物二级标准,为制药实验室和制造商提供了药典基本标准的一种方便且成本效益好的替代品。硝普钠已被广泛用作控制高血压的药物,它可通过作用于小动脉平滑肌来抑制血压升高。

應用

硝普钠可以作为分光光度法的试剂,用于使用分光光度法分析药物制剂中的美洛昔康。
这些二级标准品是经过检验的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。

分析報告

这些二级标准为USP、EP和BP 主要标准提供了多种可追溯性。

其他說明

该认证参考物质(CRM)根据ISO 17034ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。

腳註

要查看此材料的分析证书示例,请在下面的空格中输入 LRAB7818。这只是一个示例证书,可能不是您收到的批次。

象形圖

Skull and crossbones

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 3 Oral

儲存類別代碼

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Oliver Baretella et al.
Life sciences, 118(2), 206-212 (2014-01-15)
Levels of the endothelium-derived peptide endothelin-1 (ET-1) are elevated in obese humans, and ET-1 mediated vascular tone is increased. Renal arterial smooth muscle is highly responsive to ET-1. Whether or not endothelium-derived ET-1 affects contractions of the renal artery under
Antihypertensive Drugs (1997)
Gary J Hodges et al.
Experimental physiology, 99(2), 381-392 (2013-11-12)
What is the central question of this study? Previous work has produced the counterintuitive finding that the vasoconstrictor neurotransmitters noradrenaline and neuropeptide Y are involved in vasodilatation. We aimed to discover whether sympathetic neurotransmitters are required for the sustained vasodilatation
Rohit Ramchandra et al.
American journal of physiology. Regulatory, integrative and comparative physiology, 307(3), R271-R280 (2014-05-23)
Heart failure (HF) is associated with increased cardiac and renal sympathetic drive, which are both independent predictors of poor prognosis. A candidate mechanism for the centrally mediated sympathoexcitation in HF is reduced synthesis of the inhibitory neuromodulator nitric oxide (NO)
Laura A E Cox et al.
Shock (Augusta, Ga.), 43(4), 322-326 (2015-01-08)
Although endothelial dysfunction is central to the pathogenesis of sepsis, no specific and clinically applicable marker for endothelial dysfunction is currently available. Endocan, a proteoglycan excreted by endothelial cells in response to inflammatory cytokines, may serve as such a marker.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门